Mr Howard Kleinman > Dechert LLP > New York, United States > Lawyer Profile
Dechert LLP Offices
Three Bryant Park, 1095 Avenue of the Americas
NEW YORK, NY 10036-6797
NEW YORK
United States
- Firm Profile
- Go to...
Mr Howard Kleinman
Work Department
Corporate & Securities
Position
Partner, Dechert’s Corporate & Securities practice
Career
Howard Kleinman focuses his practice on capital markets and financial transactions. He represents domestic and foreign issuers, underwriters, and others in equity and debt offerings. His experience includes U.S. registered public offerings and offerings under Rule 144A private placements, offerings outside of the U.S. under Regulation S, exchange offers, debt tenders, and consent solicitations. In addition, he counsels both U.S. and non-U.S. issuers on ongoing disclosure obligations under the U.S. federal securities law and corporate governance matters. Mr. Kleinman also advises clients on mergers and acquisitions and joint ventures. Fluent in English and Spanish, Mr. Kleinman has significant experience in Latin America.
Languages
English, Spanish
Memberships
Member, International Law Section, American Bar Association; Member, The Association of the Bar of the City of New York
Education
Columbia University, B.A., 1984, Honors; The London School of Economics and Political Science, M.A., 1986; New York University School of Law, J.D., 1988, Boudin Fellowship, Articles Editor of The Journal of International Law and Politics
Lawyer Rankings
United States > Finance > Capital markets: global offerings
Dechert LLP has a background in Latin America offerings, notably those originating from Chile and Mexico. New York partner Howard Kleinman is a seasoned Latin America specialist with an extensive record in debt offerings. The firm is also active in global offerings by US issuers, including those in the life sciences and permanent capital fields. Boston’s Thomas Friedmann and New York partner David S Rosenthal lead the capital markets practice.
Latin America: International firms > Capital markets
Dechert LLP has extensive experience in representing bondholders in debt restructurings. A team led by the highly regarded Allan Brilliant represented the official committee of unsecured creditors of LATAM Airlines Group in LATAM’s chapter 11 insolvency proceedings, amongst a number of other headline debt restructurings. Howard Kleinman is another experienced Latin America specialist with a number of issuer clients in the region, particularly in Chile.
Latin America: International firms > Banking and finance
Dechert LLP is a market leader in major debt restructurings and headline bankruptcies, a forte for the firm globally. Allan Brilliant is global chair of the financial restructuring group and has a longstanding record in Latin America engagements, often representing bondholders in cross-border restructurings. He continued to lead the team that advised the Official Committee of Unsecured Creditors in the Chapter 11 cases of LATAM Airlines and its affiliates, and also represented Citadel in connection with several phases of the cross-border restructuring of Colombian carrier, Avianca. Howard Kleinman provides further senior-level experience in Latin America transactions, including in the financing field; he led the team that advised Transelec as part of a consortium of investors that were awarded a $1.5bn project finance bid for the development of a 1,500km high-voltage transmission line in Chile. At associate-level, the May-2022 hire of dual-qualifed (New York/Chile) ex-Carey lawyer, Isaac Stevens, brings additional LatAm-oriented expertise to the firm’s financial restructuring group.
Lawyer Rankings
Top Tier Firm Rankings
- Investment fund formation and management > Mutual/registered/exchange-traded funds
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Real estate > Real estate finance
Firm Rankings
- Dispute resolution > General commercial disputes
- Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Dispute resolution > Securities litigation: defense
- Finance > Structured finance: securitization
- Antitrust > Civil litigation/class actions: defense
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Dispute resolution > E-discovery
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Industry focus > Healthcare: life sciences
- Dispute resolution > International litigation
- Tax > International tax
- Dispute resolution > M&A litigation: defense
- Antitrust > Merger control
- M&A/corporate and commercial > Private equity buyouts
- Finance > Restructuring (including bankruptcy): corporate
- Intellectual property > Trademarks: non-contentious (including prosecution, portfolio management and licensing)
- Tax > US taxes: non-contentious
- Finance > Capital markets: debt offerings
- Finance > Capital markets: equity offerings
- Finance > Capital markets: global offerings
- Finance > Capital markets: high-yield debt offerings
- Labor and employment > Employee benefits, executive compensation and retirement plans: design
- Industry focus > Environment: transactional
- Media, technology and telecoms > Fintech
- Dispute resolution > International arbitration
- International Trade > International trade
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- Dispute resolution > Leading trial lawyers
- Intellectual property > Patents: litigation (full coverage)
- Investment fund formation and management > Private equity funds (including venture capital)
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense